TECX
Tectonic Therapeutic, Inc.
Key Financials
Net Income
$-74151000
↓ 27.9%
EPS (Diluted)
$-4.05
↑ 40.7%
Total Liabilities
$9.7M
↓ 20.0%
Total Assets
$261.0M
↑ 70.7%
Cash & Equivalents
$253.8M
↑ 79.7%
Shareholders' Equity
$251.3M
↑ 78.5%
Operating Income
$-84036000
↓ 44.9%
Long-term Debt
$15.0M
0.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 4/3/2026 | View on SEC |
| 4 | 4/3/2026 | View on SEC |
| 3 | 4/3/2026 | View on SEC |
| 4 | 3/9/2026 | View on SEC |
| 4 | 3/9/2026 | View on SEC |
| S-8 POS | 3/9/2026 | View on SEC |
| 144 | 3/6/2026 | View on SEC |
| 144 | 3/6/2026 | View on SEC |
| 4 | 3/5/2026 | View on SEC |
| 4 | 3/5/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | TECX |
| Company Name | Tectonic Therapeutic, Inc. |
| CIK | 1681087 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NY |
| Phone | (339) 666-3320 |